What should you know about Caris liquid biopsy?

Cancer cells can release fragments of genetic material into the bloodstream. A liquid biopsy analyses a blood sample for such material and may identify molecular changes that help the oncology team understand the cancer or consider treatment options. The exact report depends on what the ordered test examines.

A result is not a stand-alone diagnosis. Some tumours release little detectable material, so an uninformative or negative result does not exclude cancer or prove that a known cancer is absent. Blood-based testing may complement imaging, examination and a tissue biopsy rather than replace them.

Confirm why the test is being ordered, which sample is needed and whether the laboratory has given any preparation instructions. Tell the care team about your cancer diagnosis, previous biopsy findings, current medicines and recent treatment because these details provide context for interpretation.

When the report is ready, review it with the clinician who ordered it. Ask which findings are relevant, whether a tissue sample is still needed and whether any suggested option fits the cancer type, treatment history and your overall health. Do not start, stop or switch cancer treatment based only on wording in the report.

Contact the testing team if the blood-draw site develops increasing redness, swelling, warmth, discharge or bleeding that does not settle with firm pressure. Seek urgent medical help for breathing difficulty, fainting, severe weakness or another sudden serious symptom. These concerns need assessment rather than waiting for the laboratory report.

Useful questions include: What decision could this test inform? What would a negative or inconclusive result mean in my case? How will you compare the blood result with my tissue testing and scans? Could treatment already received affect what is detected? Who will explain findings that do not clearly change care?